Related references
Note: Only part of the references are listed.Stimulation of incretin secretion by dietary lipid: is it dose dependent?
Stephanie M. Yoder et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice
Eric D. Labonte et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Using the lymph fistula rat model to study the potentiation of GIP secretion by the ingestion of fat and glucose
Wendell J. Lu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones
Helen H. Wang et al.
GASTROENTEROLOGY (2008)
Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans
L. J. Karhunen et al.
REGULATORY PEPTIDES (2008)
Fasting and postprandial concentrations of GLP-1 in intestinal lymph and portal plasma: evidence for selective release of GLP-1 in the lymph system
David D'Alessio et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
The regulation of the lymphatic secretion of glucagon-like peptide-1 (GLP-1) by intestinal absorption of fat and carbohydrate
Wendell J. Lu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Meat hydrolysate and essential amino acid-induced glucagon-like peptide-1 secretion, in the human NCI-H716 enteroendocrine cell line, is regulated by extracellular signal-regulated kinase1/2 and p38 mitogen-activated protein kinases
Raylene A. Reimer
JOURNAL OF ENDOCRINOLOGY (2006)
What do we know about the secretion and degradation of incretin hormones?
CF Deacon
REGULATORY PEPTIDES (2005)
The target of ezetimibe is Niemann-Pick Cl-Like 1 (NPC1L1)
M Garcia-Calvo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia
G Salen et al.
CIRCULATION (2004)
Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption
SW Altmann et al.
SCIENCE (2004)
Niemann-Pick C1 like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis
HR Davis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The discovery of ezetimibe: A view from outside the receptor
JW Clader
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Ezetimibe for management of hypercholesterolemia
VF Mauro et al.
ANNALS OF PHARMACOTHERAPY (2003)
Ezetimibe potently inhibits cholesterol absorption but does not affect acute hepatic or intestinal cholesterol synthesis in rats
M van Heek et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Efficacy and safety of a potent new selective cholesterol absorption inhibitor, Ezetimibe, in patients with primary hypercholesterolemia
CA Dujovne et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice
HR Davis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
From interaction of lipidic vehicles with intestinal epithelial cell membranes to the formation and secretion of chylomicrons
H Shen et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs
HR Davis et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2001)
Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function
M van Heek et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: Pooled analysis of two phase II studies
HE Bays et al.
CLINICAL THERAPEUTICS (2001)
Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters
M van Heek et al.
DIABETES (2001)
The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys
M van Heek et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Cell biology - How cells handle cholesterol
K Simons et al.
SCIENCE (2000)
Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663
M van Heek et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
